Recombinant CD74 (Milatuzumab Biosimilar) antibody

Catalog No. ABIN7597823

This anti-CD74 (Milatuzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting CD74 (Milatuzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant CD74 (Milatuzumab Biosimilar) antibody (ABIN7597823)

Target: CD74 (Milatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD74 (Milatuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD74 (Milatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Milatuzumab Biosimilar Antibody

Specificity: HLA-DR antigens-associated invariant chain, HLA class II histocompatibility antigen gamma chain, CD74, CLIP, Ia antigen-associated invariant chain, DHLAG, Ii

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.77 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD74 (Milatuzumab Biosimilar)

Target: CD74 (Milatuzumab Biosimilar)

Alternative Name: Milatuzumab Biosimilar

Target Type: Biosimilar

Background: HLA-DR antigens-associated invariant chain, HLA class II histocompatibility antigen gamma chain, CD74, CLIP, Ia antigen-associated invariant chain, DHLAG, Ii

UniProt: P04233

CAS-No: 899796-83-9